Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing's syndrome: An in-vivo microdialysis study

Physiological Research

Volumn 55, Issue 4, 2006, Pages 421-428

  Krsek M ^a   Rosicka M ^a   Nedvidkova J ^b   Kvasnickova H ^b   Hana V ^a   Marek, J ^a   Haluzik M ^a   Lai, E W ^c   Pacak K ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Catecholamines; Cortisol; Fat; Glycerol; Noradrenaline

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; CATECHOLAMINE; DOPA; NORADRENALIN;

ABDOMEN; ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; GLYCEROL BLOOD LEVEL; HUMAN; IN VIVO STUDY; LIPOLYSIS; MALE; MICRODIALYSIS; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM;

ABDOMEN; ADULT; CUSHING SYNDROME; DIHYDROXYPHENYLALANINE; EPINEPHRINE; FEMALE; HUMANS; HYDROCORTISONE; LIPOLYSIS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MICRODIALYSIS; MIDDLE AGED; NOREPINEPHRINE; SUBCUTANEOUS FAT; SYMPATHETIC NERVOUS SYSTEM;

EID: 33747879402     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AXELROD J, REISINE TD: Stress hormones: Their interaction and regulation. Science 224: 452-459, 1984.
2. BJÖRNTORP P: The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 20: 291-302, 1996.
3. BROWN MR, FISCHER LA: Glucocorticoid suppression of the sympathetic nervous system and adrenal medulla. Life Sci 39: 1003-1012, 1986.
4. CAMERON OG, STARKMAN MN, SCHTEINGART DE: The effect of elevated systemic cortisol levels on plasma catecholamines in Cushing's syndrome patients with and without depressed mood. J Psychiat Res 29: 347-360, 1995.
5. DJURHUUS CB, GRAVHOLT CH, NIELSEN S, MENGEL A, CHRISTIANSEN JS, SCHMITZ OE, MOLLER A: Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol 283: E172-E177, 2002.
6. DJURHUUS CB, GRAVHOLT CH, NIELSEN S, PEDERSEN SB, MOLLER N, SCHMITZ O: Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans. Am J Physiol 286: E488-E494, 2004.
7. ESLER M, JENNINGS G, LAMBERT G, MEREDITH L, HORNE M, EISENHOFER G: Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70: 963-985, 1990.
8. GOLCZYNSKA A, LENDERS JWM, GOLDSTEIN DS: Glucocorticoid-induced sympathoinhibition in humans. Clin Pharmacol Ther 58: 90-98, 1995.
9. GOLDSTEIN DS, EISENHOFER G, STULL R, FOLIO LJ, KEISER HR, KOPIN A: Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest 81: 213-220, 1988.
10. GRAVHOLT CH, DALL R, CHRISTIANSEN JS, MOLLER N, SCHMITZ O: Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans. Obes Res 10: 774-781, 2002.
11. HALUZÍK M, NEDVÍDKOVÁ J, BARTÁK V, DOSTÁLOVÁ I, VLČEK P, RACEK P, TAUS M, SVAČINA S, ALESCI S, PACÁK K: Effects of hypo- and hyperthyroidism on noradrenergic activity and glycerol concentrations in human subcutaneous abdominal adipose tissue assessed with microdialysis. J Clin Endocrinol Metab 88: 5605-5608, 2003.
12. HALUZÍK M, PAŘÍZKOVÁ J, HALUZÍK MM.: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53: 123-129, 2004.
13. JHANWAR-UNIYAL M, RENNER KJ, BAILO MT, LUINE VN, LEIBOWITZ SF: Corticosterone-dependent alterations on utilisation of catecholamines in discrete areas of rat brain. Brain Res 500: 247-255, 1989.
14. KOPIN IJ: Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333-364, 1985.
15. LAFONTAN M, BERLAN M: Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057-1091, 1993.
16. LAMBERTS S, BIRKENHAGER J: Body composition in Cushing's disease. J Clin Endocrinol Metab 42: 864-868, 1976.
17. 2-adrenoceptor function in humans. J Clin Endocrinol Metab 80: 1804-1808, 1995.
18. LONNROTH P, JANSSON PA, SMITH U: A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 253: E228-E231, 1987.
19. 2-adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest 17: 156-165, 1987.
20. MOBLEY PL, MANIER DH, SULSER F: Norepinephrine-sensitive adenylate cyclase system in rat brain: role of adrenal corticosteroids. J Pharmacol Exp Ther 226: 71-77, 1983.
21. NEDVÍDKOVÁ J, DOSTÁLOVÁ I, BARTÁK V, PAPEŽOVÁ H, PACÁK K: Increased subcutaneous abdominal tissue norepinephrine levels in patients with anorexia nervosa: an in vivo microdialysis study. Physiol Res 54: 409-413, 2004.
22. OTTOSSON M, LÖNNROTH P, BJÖRNTORP P, EDÉN S: Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 85: 799-803, 2000.
23. PACÁK K, PALKOVITS M, KOPIN IJ, GOLDSTEIN DS: Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front Neuroendocrinol 16: 89-150, 1995a.
24. PACÁK K, PALKOVITS M, KVETNANSKY R, MATERN P, HART C, KOPIN IJ, GOLDSTEIN DS: Catecholaminergic inhibition by hypercortisolaemia in the paraventricular nucleus of conscious rats. Endocrinology 136: 4814-4819, 1995b.
25. PACÁK K, PALKOVITS M, YADID G, KVETNANSKY R, KOPIN IJ, GOLDSTEIN DS: Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am J Physiol 275: R1247-R1255, 1998.
26. POHORECKY LA, WURTMAN RJ: Adrenocortical control of epinephrine synthesis. Pharmacol Rev 24: 1-28, 1971.
27. ROBERTIS VJ, SINGHAL RL, ROBERTS DCS: Corticosterone prevents the increase in noradrenaline-stimulated adenylate cyclase activity in rat hippocampus following adrenalectomy or metopirone. Eur J Pharmacol 103: 235-240, 1984.
28. ROSDAHL H, HAMRIN K, UNGERSTEDT U, HENRIKSSON J: Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol 274: E936-E945, 1998.
29. ROSMOND R, DALLMAN MF, BJÖRNTORP P: Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83: 1853-1859, 1998.
30. SAMRA JS, CLARK ML, HUMPHREYS SM, MACDONALD IA, BANNISTER PA, FRAYN KN: Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab 83: 626-631, 1998.
31. SHEN T, GANNONG WF: Effects of variation of pituitary-adrenal activity on dopamine-β-hydroxylase activity in various regions of rat brain. Neuroendocrinology 20: 311-318, 1976.
32. UDELSMAN R, GOLDSTEIN DS, LORIAUX DL, CHROUSOS GP: Catecholamine- glucocorticoid interactions during surgical stress. J Surg Res 43: 364-370, 1987.
33. WOCIAL B, JANUSZEWICZ W, CHODAKOWSKA J, FELTYNOWSKI T: Excretion of catecholamines and their metabolites in primary hyperaldosteronism and Cushing's syndrome. Pol Tyg Lek 33: 630-631, 1978.
34. ZIEGLER, MG, RUIZ-RAMON P, SHAPIRO MH: Abnormal stress responses in patients with diseases affecting the sympathetic nervous system. Psychosom Med 55: 339-346, 1993.